FORA Capital LLC Invests $1.86 Million in Danaher Co. (NYSE:DHR)

FORA Capital LLC bought a new stake in Danaher Co. (NYSE:DHR) in the fourth quarter, HoldingsChannel reports. The fund bought 8,097 shares of the conglomerate’s stock, valued at approximately $1,859,000.

A number of other large investors also recently modified their holdings of the business. Heck Capital Advisors LLC acquired a new position in Danaher during the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher in the fourth quarter valued at $31,000. Golden State Wealth Management LLC acquired a new position in Danaher during the fourth quarter worth $31,000. Strategic Financial Concepts LLC bought a new stake in Danaher during the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC raised its position in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently weighed in on DHR shares. Jefferies Financial Group lowered their price objective on shares of Danaher from $260.00 to $230.00 and set a “buy” rating on the stock in a research note on Tuesday, April 22nd. The Goldman Sachs Group lowered their price target on Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 23rd. Wells Fargo & Company reduced their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Robert W. Baird dropped their price target on Danaher from $231.00 to $225.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Finally, Barclays lifted their price objective on shares of Danaher from $205.00 to $215.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 22nd. Five analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $264.40.

Danaher Price Performance

Danaher stock opened at $194.86 on Friday. The stock’s fifty day moving average price is $198.72 and its two-hundred day moving average price is $219.95. The firm has a market cap of $139.45 billion, a PE ratio of 36.90, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a one year low of $171.00 and a one year high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. As a group, research analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.66%. Danaher’s dividend payout ratio (DPR) is 24.85%.

Insider Buying and Selling at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares of the company’s stock, valued at approximately $3,005,442. The trade was a 51.01 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.